Trial Details

COMPLETED
Basic Information
Clinical ID c866
Identifier NCT02770040
Trial Title Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor Austin Health
City Melbourne
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2016-07-18
Primary Completion Date 2021-10-01
Completion Date 2022-09-07